logo

For the Inventor, By the Inventor

Wayne, PA, United States of America

Yan Chen

This inventor holds 15 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Biopharmaceuticals. Top assignees: Applied Molecular Evolution, Janssen Biotech, Inc., Alliedsignal Inc.. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Chen. Retrieved from https://idiyas.com/inventor/yan-chen-v80ab2bv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 93.3

 

Average Co-Inventor Count = 6.0

ph-index = 9

Forward Citations = 424(Granted Patents)


Location History:

  • Lake Hiawatha, NJ (US) (1999 - 2000)
  • Lake Hiawath, NJ (US) (1999 - 2002)
  • Wayne, PA (US) (2008 - 2014)
  • Malvern, PA (US) (2016 - 2024)

Company Filing History:

goldMedal8 out of 27 
 
Applied Molecular Evolution
 patents
silverMedal6 out of 436 
 
Janssen Biotech, Inc.
 patents
bronzeMedal4 out of 3,002 
 
Alliedsignal Inc.
 patents
4. 2 out of 144 
 
Centocor, Inc.
 patents
5. 1 out of 31 
 
Centocor Ortho Biotech Inc.
 patents
6. 2 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-IL-6 Antibody
Rheumatoid Arthritis
Biopharmaceuticals
Fluoropolymers
Peptides
Nucleic Acid Molecules
Compositions
Methods
Injectors
Dispersions
Manufacturing
Therapeutics
15 patents (USPTO):Explore Patents
1. 12065488 - Anti-IL-6 antibody (2024-08-20),
2. 11180549 - Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody (2021-11-23),
3. 9631016 - Pen-injector device containing anti-IL-6 antibodies (2017-04-25),
4. 9340613 - Anti-IL-6 antibodies, compositions, methods and uses (2016-05-17),
5. 8623362 - Anti-IL-6 antibodies (2014-01-07),
6. 8226611 - Anti-IL-6 antibodies, compositions, methods and uses (2012-07-24),
7. 8067003 - Methods of treating conditions using anti-IL-6 antibodies (2011-11-29),
8. 7833755 - Anti-IL-6 antibody nucleic acid molecules and methods (2010-11-16),
9. 7560112 - Anti-il-6 antibodies, compositions, methods and uses (2009-07-14),
10. 7365154 - Peptides antagonistic to an anti-angiogenic antibody and uses therefor (2008-04-29),
11. 6365684 - Method of manufacturing fluoropolymers (2002-04-02),
12. 6255384 - Method of manufacturing fluoropolymers (2001-07-03),
13. 6140408 - Room temperature coalescable aqueous fluoropolymer dispersions and (2000-10-31),
14. 5955556 - Method of manufacturing fluoropolymers (1999-09-21),
15. 5880204 - Room temperature coalescable aqueous fluoropolymer dispersions and (1999-03-09),

Title: The Innovative Mind of Yan Chen: A Visionary in Rheumatoid Arthritis Treatment

Introduction: Yan Chen, an accomplished inventor based in Wayne, PA, is recognized for his significant contributions to the field of biotechnology, particularly in developing treatments for rheumatoid arthritis. With an impressive portfolio of 15 patents, Chen has made strides in understanding and addressing IL-6 related conditions.

Latest Patents: Among his latest innovations are the anti-IL-6 antibodies, which have shown to be effective in treating and suppressing IL-6 related conditions, including rheumatoid arthritis. These cutting-edge methods utilizing anti-IL-6 antibodies offer new hope for patients suffering from this debilitating disease.

Career Highlights: Throughout his career, Chen has demonstrated a commitment to advancing medical science. He has worked at companies such as Applied Molecular Evolution and Janssen Biotech, Inc., where he has focused on innovative solutions to complex medical problems. His work has not only garnered patents but has also contributed to essential breakthroughs in rheumatology.

Collaborations: Collaboration has been a key element of Chen’s success. He has worked alongside esteemed colleagues like David J. Shealy and Debra Gardner, combining their expertise to push the boundaries of medical technology and treatment strategies.

Conclusion: Yan Chen’s contributions to the field of biotechnology, particularly in rheumatoid arthritis treatment, reflect his innovative spirit and dedication to improving patient outcomes. With 15 patents under his name and ongoing collaborations, his work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…